# Chronic Cardiac Resynchronization Therapy-Defibrillator Infection Leading to Sepsis and Bilateral Septic Pulmonary Emboli: A Case Report

**Authors:** Tinatin Makaridze, Tinatin Jomidava, Nikoloz Kvaratskhelia, Khatuna Jgushia, Ana Abesadze, Roin Rekvava

PMC · DOI: 10.7759/cureus.86142 · Cureus · 2025-06-16

## TL;DR

A rare case of chronic heart device infection leading to severe lung and blood infections was successfully treated with surgery and antibiotics.

## Contribution

A rare clinical case of CRT-D infection with bilateral septic pulmonary emboli and sepsis is reported and effectively managed.

## Key findings

- Chronic CRT-D infection can lead to sepsis and bilateral septic pulmonary emboli.
- Multidisciplinary management involving device extraction and targeted antibiotics successfully treated the infection.

## Abstract

Cardiac implantable electronic devices (CIEDs), including cardiac resynchronization therapy-defibrillators (CRT-Ds) and other pacemaker systems, are widely used in patients with varying degrees of heart failure to improve cardiac function and reduce the risk of sudden cardiac death. Despite their life-saving benefits, infections related to CRT-Ds present significant clinical challenges. These infections can lead to serious complications, including endocarditis, pocket infections, and device-associated bloodstream infections, often resulting in prolonged hospitalization and potentially life-threatening outcomes. Key risk factors include comorbidities such as diabetes, use of immunosuppressive therapy, and procedural complications. Early recognition and timely intervention, typically involving antibiotic therapy and/or device removal, are essential to improving patient outcomes. In this report, we describe a rare case of chronic CRT-D infection complicated by bilateral septic pulmonary emboli and sepsis, which was successfully managed through a multidisciplinary approach involving device extraction and targeted antibiotic therapy with vancomycin and cefepime.

## Linked entities

- **Chemicals:** vancomycin (PubChem CID 14969), cefepime (PubChem CID 5479537)
- **Diseases:** heart failure (MONDO:0005252)

## Full-text entities

- **Diseases:** Septic Pulmonary Emboli (MESH:D020766), Infection (MESH:D007239), pocket infections (MESH:D005888), heart failure (MESH:D006333), sudden cardiac death (MESH:D016757), Sepsis (MESH:D018805), diabetes (MESH:D003920), endocarditis (MESH:D004696)
- **Chemicals:** vancomycin (MESH:D014640), cefepime (MESH:D000077723)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12265978/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12265978/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12265978/full.md

---
Source: https://tomesphere.com/paper/PMC12265978